US approves Ranbaxy's generic Biaxin antibiotic
Facebook Twitter google+ RSS Feed

US approves Ranbaxy's generic Biaxin antibiotic

By siliconindia staff writer   |   Monday, 27 September 2004, 07:00 Hrs
Printer Print Email Email
MUMBAI: Ranbaxy Laboratories Ltd has received the US Food and Drug Administration's approval for clarithromycin, a generic form of Abbott Laboratories Inc's antibiotic Biaxin, the FDA said on Saturday.
Biaxin had sales worth $538 million in the US in 2003.

Earlier this year, the FDA had approved generic Biaxin forms from Andrx Corp and Roxane Laboratories.

Experts on SiliconIndia
Santhosh  K
Sr. Soft. Engg.
Oracle India
Nehal Vyas
Sr. Team Lead
Cyberoam Tech.
Rani Malli
Sr. Director
Sr. Executive
Vijay Balkrishna Konduskar
Business Consultant
Imans Web Tech
Dr L P  Sharma
Technical Director
Reena Khanna
Dellas  Asse
sys-network admin
Computer Station
Write your comment now
Submit Reset